Nasdaq Stockholm

Oasmia Pharmaceutical AB

ISIN SE0000722365Filings at the FI

At a glance

Most recent filing on August 19, 2021 — an open-market purchase by Anders Härfstrand on Aug 19, 2021.

We hold 19 visible filings, going back to June 15, 2017.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

What is a MAR filing?

5 of 19 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings at this company, out of 19. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Anders Härfstrand Chair of the board
53,133 SEKOpen-market buy
TradedAug 19, 2021FiledAug 19, 2021
Peter Zonabend Board member
302,624 SEKOpen-market buy
TradedJul 16, 2021FiledJul 16, 2021
Francois-Regis Martelet Chief executive officer
121,370 SEKOpen-market buy
TradedJul 13, 2021FiledJul 14, 2021
Fredrik Järrsten Konsult AB Closely associated: Chief financial officer
58,200 SEKOpen-market buy
TradedJul 14, 2021FiledJul 14, 2021
Birgit Agneta Stattin Norinder Board member
104,480 SEKOpen-market buy
TradedJul 8, 2021FiledJul 9, 2021